Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1607 of 6351
-
New hope for blood cancer patients: STP938 trial targets tough cases
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug STP938 works to treat adults with high risk essential thrombocythaemia (ET) who are resistant to, or intolerant of, hydroxycarbamide (also known as hydroxyurea) therapy. The trial will also learn about the safety of STP938. …
Phase 2 • Sponsor: Step Pharma, SAS • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a diabetes drug help teens lose weight? new study investigates
Disease control Recruiting nowThe Joule MARS study is a single center, randomized, open label clinical trial aiming to explore the metabolic adaptations that occur in response to weight management in adolescents with obesity. Behavioural lifestyle intervention with and without a pharmacological intervention -…
Phase 4 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New cream offers hope for kids with stubborn eczema
Symptom relief OngoingThe purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.
Phase 3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New obesity drug IBI362 shows promise in early trial for chinese patients
Disease control OngoingThis study is a multicenter, randomized, partially double-blind (double-blind in both the IBI362 group and the placebo group, with the tirbopeptide group open), placebo and active drug controlled design study
Phase 1/2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug inclisiran aims to lower cholesterol better in chinese heart patients
Disease control OngoingThe current study will be conducted to evaluate the real-world effectiveness of inclisiran relative to standard of care (SoC) in Chinese patients with coronary heart disease (CHD), not only with the low-density lipoprotein cholesterol (LDL-C) change in 1 year, but also the LDL-C …
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Wearable gadget aims to stop falls in neuropathy patients
Symptom relief Recruiting nowThe goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report bett…
Sponsor: RxFunction Inc. • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Simple spacer could cut hospital visits for seniors with lung disease
Disease control Recruiting nowThis study evaluates whether adding a spacer device to triple inhaled therapy (ICS/LABA/LAMA via pMDI) can reduce acute exacerbations in elderly patients (≥65 years) with stable chronic airway diseases (COPD or asthma) who are classified as high-risk based on GOLD or GINA guideli…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New daily pill CX11 shows promise for obesity in early trial
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study: * To evaluate the efficacy of different dose levels of CX11 tablets in body weight reduction as compared to placebo. * To compare the changes of effects in weight and weight-related indic…
Phase 2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New plant-based treatment aims to fight chemo fatigue in breast cancer patients
Symptom relief CompletedThe goal of this clinical trial is to determine whether Nuvastatic™ can reduce cancer-related fatigue and improve quality of life in adult female patients with breast cancer undergoing standard chemotherapy. The main questions it aims to answer are: Does Nuvastatic™ reduce canc…
Phase 3 • Sponsor: Natureceuticals Sdn Bhd • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could cannabis ease Cancer's worst side effects?
Symptom relief Recruiting nowThis study will enroll patients with cancer and participants will be randomized to receive one dose of cannabis for approximately 4 months. There is a 3/4 (or 75%) chance that a participant will receive an active cannabis dose in the study. There is a 1/4 (or 25% chance) that a p…
Phase 1 • Sponsor: Shanna Babalonis, PhD • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can robots make pediatric surgery safer? a new registry aims to find out
Knowledge-focused Stopped earlyAn open-label, observational, paediatric registry trial in which participating centers enroll subjects who had or will have a laparoscopically-assisted surgery using the Senhance Surgical System.
Sponsor: Asensus Surgical • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Pill-Sized camera could spot hidden cancers in lynch syndrome patients
Knowledge-focused Recruiting nowThe impact of small bowel (SB) capsule endoscopy (CE) on the screening (followed by diagnosis and treatment) of (pre)neoplastic lesions of the small bowel in Lynch syndrome (LS) patients is unknown. The iCARE4Lynch study is a retrospective cohort of patients carrying a pathogeni…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New drug aims to reverse liver damage from heavy drinking
Disease control OngoingThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD.
Phase 2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Surgeons test wearing a VR headset instead of staring at a screen
Knowledge-focused By invitation onlyThis study evaluates whether the Apple Vision Pro (AVP), a head-mounted display device, can be used as a virtual monitor for performing diagnostic and therapeutic procedures. Participating surgeons wear the Apple Vision Pro instead of viewing a traditional operating room monitor …
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Ear implant aims to silence ringing in the head
Disease control Recruiting nowThis study will test an experimental Tinnitus Implant System that consists of a cochlear implant, sound processor and programming software. The Tinnitus implant is surgically placed under the skin just behind the ear in the mastoid bone. It has an electrode that extends from the …
Sponsor: Cochlear • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
No drain, no problem? new study tests simpler recovery after stomach cancer surgery
Disease control Recruiting nowThis study aims to compare the effects of using prophylactic abdominal drainage tubes during Enhanced Recovery After Surgery (ERAS) in patients undergoing Laparoscopic Distal Gastrectomy (LDG) for gastric cancer through a multicenter non-inferiority randomized trial. The study is…
Phase 3 • Sponsor: Zuoyi Jiao • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study is the first human, open label, dose escalation, and expansion phase I clinical trial aimed at evaluating the safety, tolerability, preliminary efficacy, pharmacokinetic characteristics, biomarker changes, and immunogenicity of CEL001 injection in the treatment of adva…
Phase 1 • Sponsor: Guangzhou Xiling Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug targets eczema itch even when rash is mild
Symptom relief OngoingThe purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half m…
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Smart insulin pump may shield kidneys in diabetes patients
Disease control Recruiting nowThe main objective of this study is to evaluate the effect of fully automated closed-loop glucose control on renal tissue oxygenation among people with type 2 diabetes and chronic kidney disease. This is a single-center, open-label parallel design study that will compare 26 week…
Sponsor: Heba Al-Alwan • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC